PL3582808T3 - Zmodyfikowany szczep bakteryjny, który ogranicza kolonizację enterokoków opornych na antybiotyki w przewodzie pokarmowym - Google Patents

Zmodyfikowany szczep bakteryjny, który ogranicza kolonizację enterokoków opornych na antybiotyki w przewodzie pokarmowym

Info

Publication number
PL3582808T3
PL3582808T3 PL18754865.6T PL18754865T PL3582808T3 PL 3582808 T3 PL3582808 T3 PL 3582808T3 PL 18754865 T PL18754865 T PL 18754865T PL 3582808 T3 PL3582808 T3 PL 3582808T3
Authority
PL
Poland
Prior art keywords
colonization
tract
bacterial strain
resistant enterococcus
engineered bacterial
Prior art date
Application number
PL18754865.6T
Other languages
English (en)
Inventor
Nita SALZMAN
Christopher KRISTICH
Sushma KOMMINENI
Original Assignee
The Medical College Of Wisconsin, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Medical College Of Wisconsin, Inc. filed Critical The Medical College Of Wisconsin, Inc.
Publication of PL3582808T3 publication Critical patent/PL3582808T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL18754865.6T 2017-02-15 2018-02-14 Zmodyfikowany szczep bakteryjny, który ogranicza kolonizację enterokoków opornych na antybiotyki w przewodzie pokarmowym PL3582808T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762459281P 2017-02-15 2017-02-15
US201762529713P 2017-07-07 2017-07-07
PCT/US2018/018099 WO2018152148A1 (en) 2017-02-15 2018-02-14 Engineered bacterial strain that reduces antibiotic-resistant enterococcus colonization in the gi tract

Publications (1)

Publication Number Publication Date
PL3582808T3 true PL3582808T3 (pl) 2024-05-20

Family

ID=63170448

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18754865.6T PL3582808T3 (pl) 2017-02-15 2018-02-14 Zmodyfikowany szczep bakteryjny, który ogranicza kolonizację enterokoków opornych na antybiotyki w przewodzie pokarmowym

Country Status (7)

Country Link
US (1) US10920290B2 (pl)
EP (1) EP3582808B1 (pl)
AU (1) AU2018221463A1 (pl)
CA (1) CA3053543A1 (pl)
ES (1) ES2972907T3 (pl)
PL (1) PL3582808T3 (pl)
WO (1) WO2018152148A1 (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8700085A (nl) * 1987-01-15 1988-08-01 Rijksuniversiteit Werkwijze voor het bereiden van verbindingen met eindstandige hydroxyl- of epoxygroep; daarvoor bruikbare microorganismen.
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
EP1828230A2 (en) * 2004-12-16 2007-09-05 Stichting Top Institute Food and Nutrition Novel efficient process for production of capsular polysaccharides of pathogenic gram-positive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram-positive bacteria
AU2006298960B2 (en) 2005-10-06 2011-05-12 Nestec S.A. Probiotic enterococci for improved immunity
US20130236419A1 (en) * 2010-09-09 2013-09-12 The University Of Chicago Compositions and methods related to attenuated staphylococcal strains
JP6368308B2 (ja) 2012-09-07 2018-08-01 トラスティーズ・オブ・ダートマス・カレッジ 癌の診断および治療のためのｖｉｓｔａ調節剤

Also Published As

Publication number Publication date
US20200056251A1 (en) 2020-02-20
AU2018221463A1 (en) 2019-09-05
EP3582808A4 (en) 2020-11-18
US10920290B2 (en) 2021-02-16
WO2018152148A9 (en) 2019-09-12
EP3582808A1 (en) 2019-12-25
CA3053543A1 (en) 2018-08-23
WO2018152148A1 (en) 2018-08-23
WO2018152148A8 (en) 2019-08-15
AU2018221463A9 (en) 2019-09-26
EP3582808B1 (en) 2024-02-07
EP3582808C0 (en) 2024-02-07
ES2972907T3 (es) 2024-06-17

Similar Documents

Publication Publication Date Title
LT3670655T (lt) Proteinazės, turinčios pagerintas savybes
SG11202100023XA (en) Engineered immunostimulatory bacterial strains and uses thereof
IL271319A (en) Preparations containing bacterial strains
LT3313421T (lt) Kompozicija, apimanti bakterinį blautia hydrogenotrophica kamieną, skirta virškinamojo trakto bakterinės infekcijos gydymui
IL283973A (en) Preparations containing bacterial strains
PL3630136T3 (pl) Kompozycje zawierające szczepy bakteryjne
TWI559925B (en) Novel lactobacillus mali aps1 and use thereof
PT3638271T (pt) Composições contendo estirpes bacterianas
IL272491A (en) Preparations containing bacterial strains
GB201708182D0 (en) Compositions comprising bacterial strains
GB201713622D0 (en) Microbial strains and uses thereof
EP3093338A4 (en) Recombinant anaerobic gram-positive bacteria
PL3582808T3 (pl) Zmodyfikowany szczep bakteryjny, który ogranicza kolonizację enterokoków opornych na antybiotyki w przewodzie pokarmowym
PL3898938T3 (pl) Bionawożący szczep bakterii
PL3898939T3 (pl) Bionawożący szczep bakterii
GB201703548D0 (en) Compositions comprising bacterial strains
GB201919420D0 (en) Compositos comprising bacterial strains
GB201711369D0 (en) Compositions comprising bacterial strain
GB201708312D0 (en) Compositions comprising bacterial strain
GB201718551D0 (en) Compositions comprising bacterial strains
GB201714309D0 (en) Compositions comprising bacterial strains
GB201714305D0 (en) Compositions comprising bacterial strains
GB201714298D0 (en) Compositions comprising bacterial strains
GB201712851D0 (en) Compositions comprising bacterial strains
GB201712857D0 (en) Compositions comprising bacterial strains